The global population particularly in the developed economies are approaching ages nearing or surpassing the life expectancy of human beings and maintaining bone and joint health becomes very crucial, the market for bone & joint health ingredients has exceeded USD 9 billion and is thus exhibiting a promising trend.
The bone & joint health ingredients are a value-added ingredients consumed in order to strengthen and maintain healthy bones and joints. They also impart higher flexibilities that are otherwise lost with the process of aging.
The market for bone & joint health ingredients is expected to attain a CAGR of 3.8% during the forecast period (2018-2023) owing to rising demand from aging population and women suffering from micronutrients deficiency.
The rise in aging population segment is expected to be the major driving force of this market. Aging, as a biological process, leads to weakening of bone and joints, diminished functions and restricted movements. This makes the body more prone to bone fractures, arthritis, back and neck pain, osteoporosis and injuries. The number of senior citizens globally are expected to double in the next 50 years consequently pushing the demand of bone and joint health ingredients in foreseeable future.
The global bone & joint health ingredients market is segmented based on type, application and geography. Based on type of ingredients, the report contains key and widely-used ingredients like calcium, soy isoflavone, collagen, glucosamine and chondroitin.
Calcium is the most widely used bone ingredient, representing a mature market sentiment. Based on the application areas, the market is segmented into dietary supplements and functional food beverages. Soy isoflavones are another class of ingredients, gaining popularity due to its properties to reduce the leaching of calcium thereby indirectly maintaining bone mineral density (BMD) and preventing bone loss.
Bone and joint health ingredients are increasingly being incorporated into functional foods industry, with calcium fortification, glucosamine, and soy supplements gaining popularity.
The bone and joint ingredient market is highly competitive in developed regions of North America and Europe but it represents significant untapped potential in emerging economies of Asia-Pacific and Middle East.
Developed and matured markets like the U.S., Japan and the Western Europe are leading the market due to aging baby boomers, increased health-care expenditure and
heightened consumer awareness. Asian markets are increasingly witnessing the rise of products that are traditionally made from herbal source and thus carry clean labels.
MAJO RPLAYERS: SYNUTRA, INC., ROUSSELOT, ROYAL DSM NV, DUPONT, ARCHER DANIELS MIDLAND COMPANY, BASF SE, BIOIBERICA, ESM TECHNOLOGIES LLC., BERGSTORM NUTRITION INC., CARGILL, NUTRACEUTICAL INGREDIENTS PVT. LTD. (NCI), PEPTAN and BIOSCIENCE NUTRITION, amongst others.
Reasons to Purchase this Report
- Analyzing outlook of the market with the recent trends and Porter’s five forces analysis.
- Market dynamics, which essentially consider the factors that are impelling the present market scenario, along with growth prospects of the market over the forecast period.
- Market segmentation analysis, including qualitative and quantitative research, incorporating the impact of economic and non-economic aspects.
- Country-level analysis, integrating the demand and supply forces that are influencing the growth of the market.
- Competitive landscape involving the market share of major players, along with the key strategies adopted for development over the past five years.
- Comprehensive company profiles, covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players.
- 3 months analyst support along with the Market Estimate sheet (in excel).
This report can be customized to meet your requirements.
1.1 Key Deliverables of the Study
1.2 Study Assumptions
1.3 Market Definitions
2. Research Approach and Methodology
2.2 Research Design
2.3 Study Timelines
2.4 Study Phases
2.4.1 Secondary Researc
2.4.2 Discussion Guide
2.4.3 Market Engineering & Econometric Modelling
2.4.4 Expert Validation
3. Market Overview
3.1.1 Ageing population world-over
3.1.2 Rising incidences of osteoporosis and rheumatism
3.2.1 Pills and other allopathic substitutes
3.2.2 Cumbersome procedural formalities
3.3.1 Higher budgetary allocation to health-care sector
3.3.2 Elderly-friendly social-security schemes.
3.4 Porter's Five Forces Analysis
3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Threat of New Entrants
3.4.4 Threat of Substitute Products and Services
3.4.5 Degree of Competition
4. Market Segmentation
4.1 By Type
4.1.3 Soy isoflavone
4.2 By Application
4.2.1 Dietary supplements
4.2.2 Functional food & beverages
4.3 By Geography
4.3.1 North America
220.127.116.11 United States
4.3.4 South America
18.104.22.168 South Africa
5. Competitive Landscape
5.1 Strategy adopted by Key players
5.2 Most Active Companies
5.3 Market Share Analysis
6. Company Profiles
6.1 Synutra, Inc.
6.3 Royal DSM NV
6.5 Archer Daniels Midland Company
6.6 BASF SE
6.8 ESM Technologies LLC.
6.9 Bergstorm Nutrition Inc.
6.11 NutraCeutical Ingredients Pvt. Ltd. (NCI)
6.13 Bioscience Nutrition
- Synutra Inc.
- Royal DSM NV
- Archer Daniels Midland Company
- BASF SE
- ESM Technologies LLC.
- Bergstorm Nutrition Inc.
- NutraCeutical Ingredients Pvt. Ltd. (NCI)
- Bioscience Nutrition